Compound Detail
CHEMBL1922094
APITOLISIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12
Basic Information
| ChEMBL ID | CHEMBL1922094 |
| Name | APITOLISIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | YOVVNQKCSKSHKT-HNNXBMFYSA-N |
33
Targets
63
Activities
4
Assay Types
3
PK Parameters
20
Publications
8
Known Names
6
Indications
2
Mechanisms
Molecular Properties
498.6
MW (Da)
0.90
ALogP
11
HBA
2
HBD
133.8
PSA (Ų)
0.52
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase mTOR inhibitor | INHIBITOR | Serine/threonine-protein kinase mTOR | ✓ | ✓ |
| PI3-kinase class I inhibitor | INHIBITOR | PI3-kinase class I | ✓ | ✓ |
Indications
Breast Neoplasms Carcinoma, Renal Cell Endometrial Neoplasms Lymphoma, Non-Hodgkin Neoplasms Prostatic Neoplasms, Castration-Resistant
Activity Summary
IC50 36 meas. best 8.32
Kd 21 meas. best 9.21
Ki 5 meas. best 8.3
EC50 1 meas. best 6.51
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 3.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 10.96 | mL.min-1.g-1 | Homo sapiens |
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 6 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| 21981714 | 10.1021/jm2009327 | PC-3 | 4 |
| 33740547 | 10.1016/j.ejmech.2021.113357 | MDA-MB-468 | 3 |
| 27096040 | 10.1021/acsmedchemlett.6b00005 | ADMET | 3 |
| 21981714 | 10.1021/jm2009327 | MCF7 | 3 |
| 22946614 | 10.1021/jm300867c | ADMET | 2 |
| 23199076 | 10.1021/jm301389h | Mus musculus | 2 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 2 |
| - | 10.6019/CHEMBL3301361 | No relevant target | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 22084396 | 10.1158/0008-5472.can-11-1515 | A2058 | 2 |
| 21981714 | 10.1021/jm2009327 | Tyrosine-protein kinase SYK | 2 |
| 21981714 | 10.1021/jm2009327 | Mitogen-activated protein kinase kinase kinase 9 | 2 |
| 21981714 | 10.1021/jm2009327 | Tyrosine-protein kinase Fgr | 2 |
| - | 10.6019/CHEMBL3301361 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | ADMET | 2 |
| 21981714 | 10.1021/jm2009327 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
Data from ChEMBL 36 via Core Engine